Career records & work history
Lawyers & Attorneys
Kirk Gustafson - Lawyer
ISLN:
911831496
Admitted:
1971
Kirk R Gustafson, 676782 Sunnybrook Dr, Frederick, MD 21702
Kirk Gustafson Phones & Addresses
6782 Sunnybrook Dr, Frederick, MD 21702 301-6201415
Sarasota, FL
Longboat Key, FL
Severna Park, MD
San Diego, CA
Mount Airy, MD
6782 Sunnybrook Dr, Frederick, MD 21702
Mentions for Kirk R Gustafson
Kirk Gustafson resumes & CV records
Resumes
Senior Investigator
Location:
Washington, DC
Industry:
Research
Work:
National Cancer Institute
Senior Investigator National Cancer Institute-Frederick, National Institutes of Health since 1987
Senior Investigator
Senior Investigator National Cancer Institute-Frederick, National Institutes of Health since 1987
Senior Investigator
Education:
National Cancer Institute
Kirk Gustafson
Kirk Gustafson
Kirk Gustafson
Kirk Gustafson
Kirk Gustafson
Location:
United States
Publications & IP owners
Us Patents
Antiviral Proteins And Peptides, Dna Coding Sequences Therefor, And Uses Thereof
US Patent:
6987096, Jan 17, 2006
Filed:
Nov 13, 1997
Appl. No.:
08/969689
Inventors:
Michael R. Boyd - Ijamsville MD, US
Kirk R. Gustafson - Frederick MD, US
Robert H. Shoemaker - Frederick MD, US
James B. McMahon - Frederick MD, US
Kirk R. Gustafson - Frederick MD, US
Robert H. Shoemaker - Frederick MD, US
James B. McMahon - Frederick MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 31/70
US Classification:
514 44, 424 931, 424 932, 424 9321
Abstract:
The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences encoding such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.
Biologically Active Macrolides, Compositions, And Uses Thereof
US Patent:
7144918, Dec 5, 2006
Filed:
Jul 24, 2001
Appl. No.:
10/333710
Inventors:
Michael R. Boyd - Mobile AL, US
Kirk R. Gustafson - Frederick MD, US
Charles L. Cantrell - Longmont CO, US
Kirk R. Gustafson - Frederick MD, US
Charles L. Cantrell - Longmont CO, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A01N 43/02
A61K 31/335
C07D 309/00
A61K 31/335
C07D 309/00
US Classification:
514449, 549356
Abstract:
The present invention provides a compound of the formula (I). The present invention further provides a composition comprising at least one compound of the present invention and a pharmaceutically acceptable carrier, alone or in combination with at least one additional active agent. The present invention further provides a method of treating a condition treatable by the inhibition of vacuolar-type (H+)-ATPase and a method of treating cancer.
Chondropsin-Class Antitumor V-Atpase Inhibitor Compounds, Compositions And Methods Of Use Thereof
US Patent:
7205334, Apr 17, 2007
Filed:
Jul 24, 2003
Appl. No.:
10/521930
Inventors:
Michael R. Boyd - Mobile AL, US
Kirk R. Gustafson - Frederick MD, US
Kirk R. Gustafson - Frederick MD, US
Assignee:
United States of America, represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
C07D 267/22
C07D 281/18
C07D 291/00
A01N 43/16
A61K 31/35
C07D 281/18
C07D 291/00
A01N 43/16
A61K 31/35
US Classification:
514456, 540456
Abstract:
A substantially purified compound of the formula: a composition comprising a therapeutically effective amount of at least one compound of the formula, alone or in combination with at least one additional therapeutic agent, and methods of preventing or treating cancer and a condition treatable by the inhibition of vacuolar-type (H+)-ATPase.
Chondropsin-Class Antitumor V-Atpase Inhibitor Compounds, Compositions And Methods Of Use Thereof
US Patent:
7521475, Apr 21, 2009
Filed:
Feb 13, 2007
Appl. No.:
11/674245
Inventors:
Michael R. Boyd - Mobile AL, US
Kirk R. Gustafson - Frederick MD, US
Kirk R. Gustafson - Frederick MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A01N 43/16
A61K 31/35
A61K 31/35
US Classification:
514456
Abstract:
A composition comprising a substantially purified compound of the formula:.
Biologically Active Macrolides, Compositions, And Uses Thereof
US Patent:
7790764, Sep 7, 2010
Filed:
May 16, 2006
Appl. No.:
11/435189
Inventors:
Michael R Boyd - Mobile AL, US
Kirk R Gustafson - Frederick MD, US
Charles L Cantrell - Longmont CO, US
Kirk R Gustafson - Frederick MD, US
Charles L Cantrell - Longmont CO, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A01N 43/02
A61K 31/335
C07D 309/00
A61K 31/335
C07D 309/00
US Classification:
514449, 549356
Abstract:
The present invention provides a compound of formula (II). The present invention further provides a composition comprising at least one compound of the present invention and a pharmaceutically acceptable carrier, alone or in combination with at least one additional active agent. The present invention further provides a method of treating a condition treatable by the inhibition of vacuolar-type (H+)-ATPase and a method of treating cancer.
Chondropsin-Class Antitumor V-Atpase Inhibitor Compounds, Compositions And Methods Of Use Thereof
US Patent:
8278348, Oct 2, 2012
Filed:
Oct 22, 2010
Appl. No.:
12/909979
Inventors:
Michael R. Boyd - Mobile AL, US
Kirk R. Gustafson - Frederick MD, US
Kirk R. Gustafson - Frederick MD, US
Assignee:
The United States of America, as represented by the Secretary of the Department of Health and Human Services - Washington DC
International Classification:
A61K 31/35
A61P 35/00
A61P 35/02
A61P 25/28
A61P 19/10
A61P 27/06
A61P 15/08
A61P 13/00
A61P 31/10
A61P 35/04
A61P 19/08
A61P 35/00
A61P 35/02
A61P 25/28
A61P 19/10
A61P 27/06
A61P 15/08
A61P 13/00
A61P 31/10
A61P 35/04
A61P 19/08
US Classification:
514450, 514456
Abstract:
A composition comprising a substantially purified compound of the formula:.
Botryllamides And Method Of Inhibiting Pgp In A Mammal Afflicted With Cancer
US Patent:
8470888, Jun 25, 2013
Filed:
Dec 29, 2008
Appl. No.:
12/811144
Inventors:
Curtis J. Henrich - Rockville MD, US
Heidi R. Bokesch - Frederick MD, US
Laura K. Cartner - Middletown MD, US
Richard W. Fuller - Fairfield PA, US
Kirk R. Gustafson - Frederick MD, US
Kentaro Takada - Yokohama, JP
James B. McMahon - Frederick MD, US
Susan E. Bates - Bethesda MD, US
Robert W. Robey - Laurel MD, US
Suneet Shukla - Rockville MD, US
Suresh V. Ambudkar - Gaithersburg MD, US
Michael C. Dean - Frederick MD, US
Heidi R. Bokesch - Frederick MD, US
Laura K. Cartner - Middletown MD, US
Richard W. Fuller - Fairfield PA, US
Kirk R. Gustafson - Frederick MD, US
Kentaro Takada - Yokohama, JP
James B. McMahon - Frederick MD, US
Susan E. Bates - Bethesda MD, US
Robert W. Robey - Laurel MD, US
Suneet Shukla - Rockville MD, US
Suresh V. Ambudkar - Gaithersburg MD, US
Michael C. Dean - Frederick MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 31/12
C07C 59/86
C07C 59/86
US Classification:
514679, 562459
Abstract:
Disclosed are methods of enhancing the chemotherapeutic treatment of tumor cells, reducing resistance of a cancer cell to a chemotherapeutic agent, a method of inhibiting ABCG2, Pgp, or MRP1 in a mammal afflicted with cancer, and a method of increasing the bioavailability of an ABCG2 substrate drug in a mammal. The methods comprise administering effective amounts of certain compounds to the mammal, for example, a compound of the formula (I): Formula (I), wherein R, R, R, X, X, X, a, and b are as described herein. Uses of these compounds in the preparation of a medicament are also disclosed. Also disclosed are compounds of formula (II), pharmaceutical compositions comprising such compounds and uses thereof.
Chondropsin-Class Antitumor V-Atpase Inhibitor Compounds, Compositions And Methods Of Use Thereof
US Patent:
8609716, Dec 17, 2013
Filed:
Oct 1, 2012
Appl. No.:
13/632293
Inventors:
Kirk R. Gustafson - Frederick MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Services - Washington DC
International Classification:
A61K 31/35
A61P 35/00
A61P 35/00
US Classification:
514450, 514456
Abstract:
A composition comprising a substantially purified compound of the formula:.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.